Bordetella Pertussis
Bordetella Pertussis
Bordetella Pertussis
WHOOPING COUGH
Dr.T.V.Rao MD
DR.T.V.RAO MD
DR.T.V.RAO MD
HOW THE NAME WHOOPING DERIVED Whooping cough is an infectious bacterial disease that causes uncontrollable coughing. The name comes from the noise you make when you take a breath after you cough. You may have choking spells or may cough so hard that you vomit.
DR.T.V.RAO MD
IDENTIFICATION BODETELLA
Jules Bordet and Gengou contributed for discovery 1900 Identified as small bacilli in children with Whooping cough. Bodetella pertussis ( Intense cough ) Other related Bacteria B.parapertussis B.brochoseptica B.avium
DR.T.V.RAO MD
DR.T.V.RAO MD
OTHER CHARACTERS
Do not swell in the presence of antigen. Loose clumps of bacilli appear as thumb print appearance with clear space between the organisms. Freshly isolated strains have fimbria.
DR.T.V.RAO MD
CULTURE CHARACTERS
Aerobic Not anaerobic Grows optimally at 35 0 to 370 c Preferred medium Bordet Gengou glycerin potato blood agar
10
11
BIOCHEMICAL REACTIONS
In active do not ferment sugars Indole test + Reduce Nitrates Utilize citrates Splits urea
Catalase +
Oxidase +
DR.T.V.RAO MD
12
RESISTANCE
Killed by heat at 550c for 30 mt Drying and disinfectants kill the organism Survive outside for 5 days 3 days on cloths Few hours on paper
DR.T.V.RAO MD
13
DR.T.V.RAO MD
14
VIRULENCE FACTORS
These virulence factors include adhesions such as filamentous hem agglutinin, agglutinogens, peractin, and fimbriae as well as a number of toxins including pertussis toxin, acetylate cyclase toxin, trachael cytotoxins, Dermonecrtoic toxin and heat-labile toxin (CDC, 2005).
DR.T.V.RAO MD
15
PATHOGENESIS OF B.PERTUSSIS
Like most Gram negative pathogens, B. pertussis also contains a Lipopolysaccharide coat that acts as an Endotoxin and can aid colonization by agglutinating human cells (Steele, 2004).
DR.T.V.RAO MD
16
VIRULENT MOLECULES
DR.T.V.RAO MD
17
DR.T.V.RAO MD
18
MECHANISM OF INFECTION
1,2,3 are common infective strains vaccines contain all the three Agglutinogens promoting virulence by helping bacteria to attach to respiratory epithelial cells
DR.T.V.RAO MD
19
PERTUSSIS TOXIN
Pertussis toxin MW 1,17,000 Hexamer protein composed of 6 subunits with A B structure A has enzymatic activity it can be toxoided Pertussis toxin is the major component of Acellular Pertussis vaccine.
DR.T.V.RAO MD
20
NATURE OF TOXIN
It produces a highly lethal toxin (formerly called Dermonecrtoic toxin) which causes inflammation and local necrosis adjacent to sites where B. pertussis is located. The lethal toxin is a 102 kDa protein composed of four subunits, two with a mw of 24kDa and two with mw of 30 kDa.
DR.T.V.RAO MD
21
PERTUSSIS TOXIN
Causes pathogenesis
Posses Biochemical and Biological activity of producing lymphocytosis producing factor causes Lymphocytosis
Acts as Histamine sensitizing factor Islet activating function causes excessive Insulin secretion.
DR.T.V.RAO MD
22
FILAMENTOUS HEMAGGLUTININ
One of the Hemagglutinins produced by B.pertussis Filamentous Haemagglutinnins adheres to cilia of the respiratory epithelium and to erythrocytes
23
OTHER TOXINS
Adenylate cyclase
Enters the target cells and acts as toxin
It acts by catalyzing the production of cAmp by various types of cells. Heat labile Toxin
Cytoplasmic protein present in Bordetella
24
TRACHEAL TOXIN
L M W peptidoglycan Causes ciliary damage, produced by all Bodetella It induces ciliary damage in hamster tracheal ring Lipolysacchardie acts as in Gram ve bacilli
DR.T.V.RAO MD
25
Phase I to Phase II Phase III Phase IV( rough stage ) which is rough and avirulent form
DR.T.V.RAO MD
26
PATHOGENICITY
An obligate parasite Intranasal inoculation in mice induces a characteristic patches and intensive pneumonia like In humans Incubation is 1 to 2 weeks
DR.T.V.RAO MD
27
28
STAGES OF INFECTION
1 Catarrhal 2 Paroxysmal 3 Convalescent Each stage lasts 2 weeks Catarrhal stage is Maximal infective Antibiotics are useful.
DR.T.V.RAO MD
29
PAROXYSMAL STAGE
Cough increases distinctive bouts
30
DR.T.V.RAO MD
31
COMPLICATIONS
The violent bouts of cough leads to Subconjuctival hemorrhage Subcutaneous emphysema Bronchopneumonia Lung collapse Neurological complications Epilepsy, paralysis, mental retardation, blindness, deafness.
DR.T.V.RAO MD
32
EPIDEMIOLOGY
Predominately a pediatric disease Highest in the 1st year of life Maternal antibodies are not protective. Females suffers more than males. World wide in distribution Epidemics occurs periodically. In early stage of infection droplets and fomites contaminated by oropharengeal secretion are infective. Non immune rarely escape infection
DR.T.V.RAO MD
33
EPIDEMIOLOGY
House hold contacts at risk Chronic carriers are not known B.pertussis - 95 %
B.parapertussis 5%
B.brochoseptica occasionally occur Some times Adenovirus, Mycoplasma pneumonia may mimics whooping cough.
DR.T.V.RAO MD
34
DR.T.V.RAO MD
35
DIAGNOSIS
Isolation by culture PCR Direct fluorescent antibody Serological testing
DR.T.V.RAO MD
http://medinfo.ufl.edu/year2/mmid/bms5300/images/d7053.jpg
36
LABORATORY DIAGNOSIS
Microscopy Culture. Microscopy Demonstration of Bacilli in respiratory secretions. Florescent Antibody methods
DR.T.V.RAO MD
37
DR.T.V.RAO MD
38
39
DR.T.V.RAO MD
40
NASOPHARYNGEAL SWAB
Secretion from the posterior pharyngeal wall are collected with cotton swab on a bent wire passed from the oral cavity A Wests post nasal swab is used for collection of specimen.
DR.T.V.RAO MD
41
42
TRANSPORT MEDIUM
Transferred into Casamio acid solution at pH 7.2 in modified Stuarts medium Glycerin potato blood agar of Bordet Gengou Adding Pencillin becomes more selective
DR.T.V.RAO MD
43
IDENTIFICATION OF BACTERIA
The culture plates are incubated at 360c The bacteria are identified by Microscopy and slide agglutination
Immunofluorescence methods
DR.T.V.RAO MD
44
SEROLOGY
Paired serum sample for detection of antibodies Gel precipitation testing Complement fixation test Detection of Ig A by ELISA from nasopharyngeal secretions.
DR.T.V.RAO MD
45
DR.T.V.RAO MD
46
47
PROPHYLAXIS
Alum absorbed vaccine is better Administered in combination with Diphtheria, and tetanus toxoid B pertussis acts as an adjuvant Early immunization, is essential in prevention of infection. Later doses are given at the interval of 4 6 weeks intervals, before 6 moths 3 doses are completed.
DR.T.V.RAO MD
48
BOOSTER DOSES
A booster at the end of the 1 st year Another dose at 4th year Chemoprophylaxis with Erythromycin when exposed to contacts in the vicinity Complications with vaccination Post vaccinial encephalopathy 5 10 million doses Neurotic complications Stop further vaccination Do not vaccinate after 7 years
DR.T.V.RAO MD
49
50
ACELLULAR VACCINES
Contain the Pertussis bacilli Contain PT FHA Agglutinogens 1, 2, 3 Produces immunity in 90 % of individuals Immunity in only 50 % by 12th year
DR.T.V.RAO MD
51
TREATMENT
Penicillin is not useful 10 days of Erythromycin is useful in early infection
52
DR.T.V.RAO MD
53